Pharmafile Logo
Pharmafocus logo
Advanced Search
covid_cell_1_20

MHRA confirms registration of Avacta’s lateral flow test

June 7, 2021
Sales and Marketing COVID-19, EU, MHRA, lateral flow test

Avacta has announced that the MHRA has confirmed registration of the AffiDX SARS-CoV-2 antigen lateral flow test, which allows the …

News
regeneron

Regeneron’s COVID-19 antibody EUA reduced to lower dose by FDA

June 7, 2021
Sales and Marketing

The FDA has updated the Emergency Use Authorisation (EUA) for Regeneron Pharmaceuticals’ COVID-19 antibody cocktail, REGEN-COV, halving the dose from …

News
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

June 4, 2021
Medical Communications

Among our ten most-read stories this week: NICE rejects risdiplam for treating spinal muscular atrophy; The EU wants to Fine …

News
novartis_window

Novartis’s 177Lu-PSMA-617 reduces prostate cancer death risk by 38%

June 4, 2021
Medical Communications

Novartis’s 177Lu-PSMA-617 has shown to significantly improve overall survival and radiographic progression-free survival for men with metastatic castration-resistant prostate cancer …

News

BMS announce new positive data from oesophageal cancer study

June 4, 2021
Medical Communications Cancer, oncology

Bristol Myers Squibb (BMS) has announced results from the Phase III CheckMate -648 trial in which nivolumab plus chemotherapy and …

News

Phase III trial shows Olaparib reduces breast cancer recurrence by 42%

June 4, 2021
Medical Communications

Results from OlympiA’s Phase III trial has shown that its Olaparib (Lynparza) in the adjuvant treatment of patients with germline …

News

J&J’s Tremfya sees positive results for post-TNFi psoriatic arthritis

June 4, 2021
Medical Communications J&J, JJ

Johnson & Johnson’s interleukin-23 (IL-23) Tremfya (guselkumab) has shown positive results in Phase IIIb trials, in post-tumour necrosis factor (TNF) …

News
cdc-un8tv9pw2ik-unsplash_1

WHO approves China’s Sinovac COVID-19 vaccine

June 3, 2021

China’s Sinovac COVID-19 vaccination has received an emergency use listing (EUL) from the WHO. This decision means the jab can …

News
hd_map

Vaccine patch outperforms needle-and-syringe jabs in pre-clinical study

June 3, 2021
COVID-19, Vaccine, technology

Vaxxas, an Australian clinical-stage biotechnology company, has announced positive results from pre-clinical trials into its novel high-density microarray patch (HD-MAP) …

News

Phase III traumatic brain injury trial does not meet primary endpoint

June 3, 2021

vasopharm GmbH has announced that its NOSTRA III traumatic brain injury (TBI) Phase III clinical trial of ronopterin did not …

News

Novartis report longest median OS in breast cancer study

June 3, 2021
Novartis, breast cancer, trials

Novartis has announced updated median overall survival (OS) results for Kisqali (ribociclib), in combination with fulvestrant, in postmenopausal women with …

News

Organon launches as women’s health company

June 3, 2021

Organon has today launched through a spinoff from Merck as a global company focusing on women’s health. The new team …

News

Biosimilars and Brexit: What’s in store for UK’s biosimilar market?

June 2, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biosimilars, brexit

It’s been 15 years since the first biosimilar entered the market, and the impact of these drugs on the healthcare …

Feature

The importance of representation in clinical trials

June 2, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Representation, clinical trials

Before any kind of new medicine can be made available to the market, it has to go through a strictly …

Feature

Softbox brings in Sean Austerberry as new Director

June 2, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Softbox Systems has appointed Sean Austerberry as its Research and Product Development Director. Sean will be responsible for all of …

Appointment
robert_obeirn

Sharp adds Robert O’Beirn to its Global Clinical Services Business

June 2, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Sharp has appointed Robert O’Beirn as SVP and Managing Director of its global Clinical Services business. In early 2019 Mr …

Appointment
deb_hussain

Debra Hussain new CCO of Acacia Pharma

June 2, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Acacia Pharma has appointed Debra Hussain as Chief Commercial Officer. She is a highly experienced commercial leader having spent over …

Appointment
natalie_berner

Redx installs Natalie Berner as Non-Executive Director

June 2, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Redx Pharma has appointed Natalie Berner as a Non- Executive Director, she will represent RM Special Holdings 3 LLP on …

Appointment

J&J appoints Charmaine England as MD for Consumer Health Northern Europe

June 2, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

 

Appointment
roche__tree

NICE rejects risdiplam for treating spinal muscular atrophy

June 2, 2021
Research and Development

NICE has issued draft guidance today which does not recommend Roche’s risdiplam (Evrysdi) for treating the rare genetic disorder spinal …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026